ReviewFrontiers in microbiology2020
Timely Diagnosis of Histoplasmosis in Non-endemic Countries: A Laboratory Challenge.
Review in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 22 citations in OpenAlex.
- Biomarkers in Invasive Pulmonary Fungal Infections: Where Do We Stand?Journal of fungi (Basel, Switzerland) · 2026Review
- Hidden Histoplasmosis: Adrenal and Central Nervous System Mycosis in an Immunocompetent Patient.Cureus · 2025Article
- Radiological features of chronic pulmonary histoplasmosis: Easily mistaken for tuberculosis.PLoS neglected tropical diseases · 2025Review
- Histoplasma Infection in a Case of Multiple Myeloma Presenting as a Diagnostic Conundrum.South Asian journal of cancer · 2025Article
- Usefulness of Serum as a Non-Invasive Sample for the Detection ofJournal of fungi (Basel, Switzerland) · 2025Article
- A Diagnostic Dilemma: Disseminated Histoplasmosis Presenting as a Small-Bowel Obstruction.The American journal of case reports · 2025Article
- Disseminated Histoplasmosis Presenting with Panniculitis and Macrophage Activation Syndrome in a Patient Undergoing Immunosuppressive Therapy for Mixed Connective Tissue Disease (MCTD).Internal medicine (Tokyo, Japan) · 2025Article
- Disseminated Histoplasmosis: A Rare Cause of Pancytopenia in an Immunocompromised Patient.Cureus · 2022Article
- Histoplasmosis in Children; HIV/AIDS Not a Major Driver.Journal of fungi (Basel, Switzerland) · 2021Review
- Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020.Journal of fungi (Basel, Switzerland) · 2021Review
- Subcutaneous Mycoses in Travelers.Current tropical medicine reports · 2020Article
- Point of care tests for invasive fungal infections: a blueprint for increasing availability in Africa.Therapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human histoplasmosis is a fungal infection caused by the inhalation of microconidia of the thermally dimorphic fungi
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.